Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?

Published:2022-01-18 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Rich Nicole E.¹^ORCID,Singal Amit G.¹^ORCID

Affiliation:

1. Division of Digestive and Liver Diseases UT Southwestern Medical Center Dallas Texas USA

Funder

Division of Cancer Prevention, National Cancer Institute

American College of Gastroenterology

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32284

Reference147 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021

2. Contemporary epidemiology of chronic liver disease and cirrhosis;Moon AM;Clin Gastroenterol Hepatol,2020

3. Prognosis of hepatocellular carcinoma: the BCLC staging classification;Llovet JM;Semin Liver Dis,1999

4. Natural history of untreated hepatocellular carcinoma in a US cohort and the role of cancer surveillance;Khalaf N;Clin Gastroenterol Hepatol,2017

5. EASL clinical practice guidelines: management of hepatocellular carcinoma;Galle PR;J Hepatol,2018

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-contrast abbreviated MRI for the detection of hepatocellular carcinoma in patients with Liver Imaging Reporting and Data System LR-3 and LR-4 observations in MRI;British Journal of Radiology;2024-08-08

2. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients;JAMA Network Open;2024-04-29

3. Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells;Biomarker Research;2024-04-09

4. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis;Liver Transplantation;2024-03-05

5. Benefits and harms of polygenic risk scores in organised cancer screening programmes: a cost-effectiveness analysis;The Lancet Regional Health - Western Pacific;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3